Drugs / C-13 labeled Lysine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03063476 | Mar → May 2017 | — | Vanderbilt University Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C-13 labeled Lysine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03063476 ↗ |
| Modality | Other / unclassified | “Lysine is one of the twenty essential amino acids” NCT03063476 ↗ |
| Route | Oral | “subjects will be given an oral bolus of C-13 labeled lysine (5 g) in 50 ml water.” NCT03063476 ↗ |